Non-walled spherical Acinetobacter baumannii is an important type of persister upon β-lactam antibiotic treatment

ABSTRACT Bacterial persistence is one of the major causes of antibiotic treatment failure and the step stone for antibiotic resistance. However, the mechanism by which persisters arise has not been well understood. Maintaining a dormant state to prevent antibiotics from taking effect is believed to be the fundamental mechanistic basis, and persisters normally maintain an intact cellular structure. Here we examined the morphologies of persisters in Acinetobacter baumannii survived from the treatment by three major classes of antibiotics (i.e. β-lactam, aminoglycoside, and fluoroquinolone) with microcopy and found that a fraction of enlarged spherical bacteria constitutes a major sub-population of bacterial survivors from β-lactam antibiotic treatment, whereas survivors from the treatment of aminoglycoside and fluoroquinolone were less changed morphologically. Further studies showed that these spherical bacteria had completely lost their cell wall structures but could survive without any osmoprotective reagent. The spherical bacteria were not the viable-but-non-culturable cells and they could revive upon the removal of β-lactam antibiotics. Importantly, these non-walled spherical bacteria also persisted during antibiotic therapy in vivo using Galleria mellonella as the infection model. Additionally, the combinational treatment on A. baumannii by β-lactam and membrane-targeting antibiotic significantly enhanced the killing efficacy. Our results indicate that in addition to the dormant, structure intact persisters, the non-wall spherical bacterium is another important type of persister in A. baumannii. The finding suggests that targeting the bacterial cell membrane during β-lactam chemotherapy could enhance therapeutic efficacy on A. baumannii infection, which might also help to reduce the resistance development of A. baumannii.


Introduction
The treatment failure on bacterial infection diseases has become a global crisis again only less than 100 years after the first antibiotic was introduced for clinical use. On the one hand, the mis-or over-use of antibiotics in the past several decades have led to the rapid evolution of antibiotic resistance in almost all the major bacterial pathogens, resulting in an increasing scarcity of an effective antibiotic. On the other hand, bacterial persistence has augmented the difficulties in the effective treatment by the limited source of antibiotics. Different from antibiotic resistance, bacterial persisters are a sub-population of isogenic bacteria that can survive the prolonged exposure to high concentration of antibiotics without generating any genetic variation to counteract the bactericidal effects of the antibiotics. Bacterial persisters were first identified in 1944 by Joseph Bigger, who found that a small portion of Staphylococcus population was not killed by penicillin but still kept the susceptibility to the same antibiotic after re-growth [1]. Although bacterial persistence has been noticed for seven decades, it was appreciated only recently as one of the major causes of antibiotic recalcitrance and relapse of infection diseases [2][3][4][5].
In addition to resulting in the chronic bacterial infections, persisters can provide a viable cell reservoir from which resistant mutant can emerge by de novo chromosomal mutation or horizontal gene transfer, functioning as a stepping stone for the evolution of antibiotic resistance [6][7][8]. Furthermore, persistence is also able to promote the evolution of antibiotic resistance by increasing the mutation rates [9]. Therefore, an effective eradication of bacterial persisters will not only prevent treatment failure of chronic infection but also alleviate the development of antibiotic resistance. Understanding the underlying mechanism of persistence formation will aid the development of such effective therapeutic approach.
While the clinical implications of bacterial persistence have been well demonstrated [10], the mechanisms by which persisters arise and the basis for drug tolerance are yet to be fully elucidated [11,12]. Cell dormancy has long been considered as the fundamental mechanism for the formation of persisters. In this model, antibiotics cannot exert their lethal effects even after they bind to their targets, because the bacteria are in a dormant state and the downstream pathways of antibiotic-drug interaction are inactive. Such dormant persisters maintain an intact cellular structure [5]. Several factors, such as toxin-antitoxin module, (p)ppGpp, SOS response pathways and intracellular ATP level, contribute to the dormancy of the cells [4]. Additionally, actively pumping out the intracellular antibiotics by efflux pump also facilitate the dormancy of bacterial persisters [13,14].
Acinetobacter baumannii is a gram-negative coccobacillus that is aerobic, pleomorphic and non-motile. It has emerged as a highly troublesome pathogen responsible for a broad range of nosocomial infections, including ventilator-associated pneumonia and bloodstream infections with a high mortality rate [15]. In addition, A. baumannii is also a causative agent for skin and soft tissue infections, secondary meningitis and wound infections [16]. Importantly, A. baumannii has remarkable ability to acquire resistance. In fact, it has developed resistance to almost all known antibiotics, and the multiple drug resistance (MDR) has also been widely documented [17,18]. The clinical importance of A. baumannii was emphasized recently by World Health Organization (WHO), and A. baumannii was selected as the priority 1 (critical) pathogen among its "priority pathogens" list for research and development related to new antibiotics [19]. In addition to the widespread of drug resistance, A. baumannii persistence also contributes to the treatment failure even at high doses of antibiotics [20]. Despite the endeavours have been made to understand the persistence and its eradication [21][22][23][24], the mechanism for persistence formation in A. baumannii is yet to be fully understood.
In this study, we investigated the morphologies of A. baumannii persisters produced by different antibiotics and found a major faction of enlarged spherical cells presenting in persisters survived from β-lactam antibiotic killing. Subsequently, we found that β-lactam antibiotics efficiently inhibited the cell wall synthesis in A. baumannii and formed non-walled spherical cells. The non-walled spherical A. baumannii demonstrated enlarged cellular size and was able to persist under both in vitro and in vivo conditions as a new type of persisters. Treatment of A. baumannii by the combination of β-lactam and cell membrane-targeting reagent enhanced the killing of the pathogens. Our study identifies a new type of persisters featured by active metabolism and damaged cellular structure and provides a promising approach for the efficient treatment of A. baumannii infection.

Bacterial strains, plasmids and growth conditions
The bacterial strains and plasmids used in this study are listed in Table S1. LB broth was used for all the experiments except for combinational killing assay, in which cation-adjusted Mueller-Hinton broth (MHB) medium was used. Culture media were supplemented with 10 μg/mL tetracycline when necessary.

Bacterial strain construction
The strain containing dnak::msfGFP translational fusion was constructed by SacB-mediated allelic exchange following previous description [25] with the suicide plasmid pEXG2 harbouring a fragment of dnak gene, msfGFP gene which was amplified from the template plasmid of pWM91_VipA-msfGFP [26] and a fragment of DNA sequence downstream of dnaK gene on the chromosome. Primers used are listed in Table S2.

Isolation of persisters and bacterial killing assay
The bacterial killing was performed as described previously [27] and a detailed protocol is provided in supplementary experimental procedures.

Fluorescent microscopy
Bright field and fluorescence imaging were performed on an inverted microscope (Carl Zeiss Axio Observer Z1). Appropriate filter sets were selected for each dye according to their excitation and emission spectra. HADA was imaged in DAPI channel and falsecoloured in red. Flow Cell System FCS2 (The Focht Chamber System 2, Bioptechs) was used to record prolonged bacterial killing and re-growth. Detailed information is described in supplementary experimental procedures.

Image acquisition and analysis
All microscopy images were analysed by ImageJ software (Fiji). The bacterial surface area was measured from bright-field images and the pixel intensity within a cell was measured from the fluorescence emission channel.

Galleria mellonella infection model
G. mellonella caterpillars in the final-instar larval stage were used in this study and infections were conducted, as described previously [28,29]. Detailed information is described in supplementary experimental procedures.

Determination of the fractional inhibitory concentration index (FICI)
The FICI was determined, as described previously [30]. Detailed information is provided in supplementary experimental procedures.

A. baumannii persisters from antibiotic killing demonstrates distinct morphotypes
We attempted to investigate the persistence in A. baumannii by conducting a dose-dependent antibiotic killing on A. baumannii ATCC17978 with a representative from the three major classes of antibiotics, namely meropenem (β-lactam), kanamycin (aminoglycoside) and ofloxacin (fluoroquinolone) ( Fig. S1A-S1C). A concentration of antibiotic that kills about 99.99% of bacteria after 4 h incubation was chosen for each of these antibiotics: 6 µg/mL for meropenem, 40 µg/mL for kanamycin and 40 µg/mL for ofloxacin. Bacterial cultures treated with such a concentration of individual antibiotic demonstrated a classic biphasic killing curve, a characteristic for bacterial persisters (Figure 1(A-C)) [31,32]. The frequency of persisters obtained from the bacterial culture was 5.3 × 10 −7 for kanamycin, 8.5 × 10 −5 for ofloxacin and 2.2 × 10 −5 for meropenem.
The untreated A. baumannii demonstrated pleomorphism: the majority cells showed a short rod morphotype, and a small portion of bacteria resembled the coccobacilli or the long rod bacteria (Figure 1(D)). Upon treatment by antibiotics, most of bacteria were killed, as few bacteria could be visualized under microscope in the bacterial culture without being concentrated. The morphotype of the observed bacteria treated by kanamycin or ofloxacin was less changed (Figure 1(D)), though an increasing number of longer rod cell were observed in bacteria treated with ofloxacin. In contrast, a significant number of bacteria treated by lethal concentration of meropenem demonstrated a dramatic morphological change: the cells turned into spherical shape and got enlarged (Figure 1(D)). This is in consistent with the previous observation [33]. We stained the bacteria with SYTO-9 and propidium iodide (PI). Our results showed that the majority of cells observed under microscope were both SYTO-9 positive and PI negative, including the spherical A. baumannii produced by meropenem treatment, suggesting that the cells observed are still viable.
For direct visualization the cell morphotypes in vitro and in vivo, we engineered a chromosomal msfGFP fusion at the C-terminal of DnaK in A. baumannii ATCC17978 to produce the strain of dnak::msfGFP. DnaK was known to be expressed during antibiotic treatment in A. baumannii [34]. Bacteria with DnaK:: msfGFP can be easily visualized under microscope. The bacterial derivative demonstrated a similar response to meropenem (Fig. S1D). Similarly, the treatment of A. baumannii with 150 µg/mL carbenicillin resulted in a killing curve that bacterial survivors at 4 h post-treatment could largely represent the persister cells ( Fig. S1E and S1F). Bacterial survivors from carbenicillin-treated dnak::msfGFP culture showed a similar spherical shape as those treated by meropenem ( Figure  1(E)) and were distinct from the bacteria untreated or those treated by kanamycin or ofloxacin (Figure 1(D)). Extension on the incubation time with the carbenicillin or meropenem up to 11 h or 24 h did not eliminate them from the culture ( Fig. S1G and S1H). These results suggest that the spherical cells are a common morphotype for the bacteria that survive the killing by lethal concentration of β-lactam antibiotics.

Spherical A. baumannii is persisters that can revive
To confirm that spherical bacteria are bona fide persisters that can revive upon the removal of antibiotics, rather than the viable-but-non-culturable cells (VBNCs), we monitored the formation of spherical bacteria upon meropenem treatment and their regrowths after the removal of antibiotics with FCS2 device, a temperature-controlled flow cell system. We found that bacteria become spherical after 60 min antibiotic treatment and simultaneously the size of bacterial cells started to increase. Time-lapse microscopy showed that spherical cells first protruded from one side or two sides of the bacteria, likely the broken site of the cell wall, and then the whole cell escaped from one point and eventually formed the spherical cell. As the size increased, some of the spherical cells got burst. However, a significant number of the enlarged spherical cells still persist after 470 min post-antibiotic treatment (Figure 2(A) and Movie S1). We also noticed that a transient protrusion occurred from some of the spherical enlarged cells and then the cell size got reduced or burst.
The ability of the spherical bacteria to divide upon the removal of β-lactam antibiotics was then examined. A. baumannii culture was firstly treated with 10 µg/mL meropenem for 4 h, followed by washing to remove the residual antibiotics. Bacterial survivors were then concentrated and observed by time-lapse microscopy. The fresh LB medium was provided to these cells using the FCS2 device during observation. Consistently, meropenem treatment produced the spherical bacteria with enlarged size. Time-lapse imaging of the spherical bacteria showed that they started to divide at 60 min after the fresh LB medium was provided and eventually formed colonies (Figure 2(B) and Movie S2). These results suggested that the spherical bacteria produced by β-lactam antibiotics are viable and re-growable, but not VBNCs. The re-grown bacteria were still sensitive to the same antibiotic and turned into spherical morphotype from the normal cells upon treatment ( Fig. S2A and S2B). Importantly, the isolated persisters demonstrated a comparable minimum inhibition concentration (MIC 50 ) for each antibiotic with that of bacteria before antibiotic treatment ( Fig S3 and Table S3). Our results collectively suggest that the isolated persisters did not acquire any resistance. Thus, the spherical A. baumannii is a new type of persister.

Spherical persisters completely lose their cell walls
We next asked whether the spherical bacteria observed were those lost the cell wall or simply dormant cells that changed their morphotypes. We employed the fluorescent D-amino acid analogue HCC-amino-Dalanine (HADA) to label the peptidoglycan (PG) of the cell walls in A. baumannii dnak::msfGFP that expressed GFP. HADA can be specifically incorporated into PG and can be widely used for probing the presence of bacterial cell wall in other bacterial species [33,35]. Similarly, HADA was incorporated into both exponential and stationary phases of A. baumannii (Fig. S4). We found that nearly 100% of the A. baumannii dnak::msfGFP or Escherichia coli (expressing eGFP) grown in LB media are labelled by HADA (Figure 2(C,D), upper panel). The bacteria gave both green and red fluorescence, indicating that they are live bacteria with an intact cellular structure. Upon meropenem exposure, most A. baumannii turned dim or became negative in green fluorescence, while were still positive in red fluorescence, suggesting that the bacteria are dead and cytoplasm might have been released, left an empty cell wall skeleton. However, we observed that the spherical persisters were positive in green fluorescence but negative in red fluorescence, suggesting that these persisters lost their cell wall completely (Figure 2(C), lower panel). Similarly, almost all E. coli treated by meropenem became green fluorescence negative, suggesting that the cells are dead. The few remaining E. coli positive in both green and red fluorescence resembled the same rod shape morphotype as those untreated bacteria ( Figure  2(D), lower panel), suggesting that the persisters in E. coli are mainly dormant persisters with an intact cellular structure.
The ratio of spherical bacteria was then quantified under microscope. About 68.6% of persistent cells in A. baumannii culture after treatment by meropenem were spherical with an enlarged bacterial size, in contrast to only ∼8.7% of spherical bacteria in E. coli. Furthermore, 51.8% of the spherical persisters of A. baumannii, compared to 8.2% of E. coli, were totally negative in HADA labelling. In addition to the spherical persisters, ∼31.4% of persisters in A. baumannii exhibited the same non-spherical rod shape as untreated bacteria, and 20.4% of them were HADA positive, suggesting that they are likely the dormant persisters. In contrast, ∼91.2% E. coli persisters in cultures treated by meropenem remained the same rod shape as untreated, among which 89.5% of them were HADA positive (Figure 2(C-E)).
To quantify the increases in bacteria size observed in spherical cells, the surface area of A. baumannii perisisters from meropenem treatment was analysed by ImageJ (Fiji). A. baumannii grown in LB media demonstrated an average surface area of 0.81 ± 0.15 μm 2 (Figure 2(F)). In contrast, the surface area of non-walled spherical persisters in A. baumannii treated with meropenem increased dramatically, reaching an average of 4.23 ± 1.37 μm 2 (Figure 2(G)). However, the persister of E. coli, mainly in non-spherical rod shape, and produced after the treatment with meropenem, showed a similar surface area (1.03 ± 0.44 μm 2 ) as untreated (1.03 ± 0.23 μm 2 ) (Figure 2(H-I)).

A. baumannii forms spherical persisters in vivo
We next asked whether the non-walled enlarged spherical A. baumannii was produced and persisted in host environment. We infected larvae of G. mellonella, a widely used animal model for studying the pathogenesis and antimicrobial treatment involved in A. baumannii [28,36,37], with dnak::msfGFP. After 3 h infection with A. baumannii, the haemolymph of G. mellonella was extracted every hours from larvae for observation with fluorescent microscope. Most of A. baumannii cells in haemolymph isolated from untreated G. mellonella were in short rod shape with normal size, suggesting that the bacteria maintain an intact cell wall. A few A. baumannii cells showed spherical shape with increased cell size (Figure 3(A)). These enlarged spherical A. baumannii are likely produced by lysozyme in the haemolymph, which has been shown to produce non-walled L-form in Bacillus subtilis [29]. To test if β-lactam antibiotics could enhance the ratio of spherical cells in vivo, we treated the larvae with meropenem at 1 h after infection by dnak::msfGFP. At 30 min post treatment, the haemolymph was extracted, and the bacteria were examined under microscope. Compared to bacteria in untreated haemolymph, an increased number of bacteria isolated from the treated G. mellonella showed a spherical shape: 31.2% of bacterial survivors are spherical shape compared to 1.4% in the controlled group (Figure 3(B,C)). Therefore, spherical A. baumannii persisters could be formed during the therapeutic process in the host environment upon treated by β-lactam antibiotics.

Membrane targeting agents enhance the killing of β-lactam antibiotics
Since the spherical persisters have lost their cell walls, we hypothesized that the addition of membranedamage agent during β-lactam antibiotic treatment could produce a synergistic effect and enhance bacterial killing by β-lactam antibiotics. A low concentration (1%) of Triton X-100, a common non-ionic detergent that damages cell membrane, alone does not affect the survival of untreated A. baumannii. However, its addition to A. baumannii meropenem treatment enhances the killing potency of the antibiotic by about 50%. In contrast, addition of 1% Triton X-100 A. baumannii during the treatment by kanamycin or ofloxacin did not produce any synergistic effect ( Figure  4(A)).
Colistin is the last-resort antibiotic for multidrugresistant gram-negative organisms including A. baumannii, and it targets the lipopolysaccharide and can dissolve bacterial membrane. However, it has nephrotoxicity and neurotoxicity at high dose [38,39]. We found that a low concentration of colistin (2µg/mL), which had little killing effect on bacteria by itself, could sufficiently enhance the killing potency of meropenem by over 100-fold (Figure 4(B)). Importantly, the synergistic effect was observed not only between colistin and meropenem, but also with other β-lactam antibiotics (i.e. ampicillin and carbenicillin), with an increasing in killing on A. baumannii by a range of 100-to 1000-fold (Figure 4(C,D)). Furthermore, the enhanced killing efficiency was also observed when the combination of carbenicillin and colistin was used to treat two clinical isolates (Iso 03126 and Iso 03368) of A. baumannii ( Fig. S5A and S5B). The synergistic effect of the combination of colistin and β-lactam antibiotics on bacterial growth was also investigated by fractional inhibitory concentration index (FICI), and the combination of colistin with ampicillin or meropenem showed significant synergistic effect, whereas no significant synergistic effect between colistin and carbenicillin was observed (Table S4). Considering that FICI reflects the inhibitory but not bactericidal effect of the drugs at low concentration, whereas the killing assay by CFU enumeration examines their bactericidal effect at high concentration, it is thus not surprised to see the dramatic potentiation of colistin on β-lactam killing but less significant in enhancing the inhibition of bacteria growth in the FICI assay.

Discussion
Bacterial persistence is one of the major causes of antibiotic treatment failure and infection relapse. Dormancy has been recognized as the basic mechanism for the persistence [2][3][4]. The inactive metabolism in dormant bacteria results in the failure of antibiotic accumulation to an effective concentration that can cause enough damage to bacterial cells for a lethal effect. In this report, we found that the treatment of A. baumannii with β-lactam successfully damaged/ inhibited the bacterial cell wall and produced the non-walled, enlarged spherical cells. Our results suggest that the non-walled, enlarged spherical cells represent another type of bacterial persisters other than the dormant persistersthey are metabolically active (as demonstrated by the cell wall being damaged) and are able to survive without intact cell wall.
Persisters were less studied until 1998, when Falla and Chopra isolated a mutation in the hipA, termed hipA7, that enhanced the persistence formation by 100-1000 times [40]. HipA is the toxin of toxin-antitoxin module HipBA [41]. Under stress condition, HipA was activated to halt protein translation and bacterial growth, resulting bacteria into a physiologically dormant state [42][43][44][45]. Subsequently, the involvement of several other toxin-antitoxin modules in the persistence formation was shown although there are some instances of counter-evidence challenging their roles [46]. In addition to triggering bacteria to dormancy by activating toxin, lowering intracellular ATP levels and enhancing protein aggregates accumulation both increased the formation of persistence [47,48]. Complementary to driving bacteria to dormancy, enhancing the activity of efflux pump was also demonstrated to facilitate the persistence [14]. Accumulatively, the strategy for persistence used by dormant persisters is to lower its metabolic activities and prevent the antibiotic from effectively damaging their targets so that bacteria can survive from killing and persist. Such persisters maintain an intact cellular structure.
However, our study suggests that different type of persisters likely exist: these types of persisters are metabolically active as their cellular structures have been damaged. Such persisters can be generated by cell wall targeting agent. β-lactam is a group of antibiotics that inhibit the catalytic enzymes involved in cell wall synthesis, named penicillin-binding proteins (PBPs), resulting in cell wall-deficient spheroplast. The nonwalled spheroplast is liable to lysis driven by high internal osmotic pressure present in bacteria, defining the killing mechanism of β-lactam antibiotics. In our study, β-lactam antibiotics have successfully inhibited the cell wall synthesis, producing the non-walled spherical bacteria. However, different from E. coli a significant number of non-walled spherical A. baumannii bacteria were still able to survive both in vitro and in vivo. Apparently, non-walled spherical A. baumannii were under high internal osmotic pressure, judged by the enlarged cellular size visualized under microscope.
Although cell wall is vital for the survival of bacteria, several bacterial species can survive and proliferate without cell wall, named L-form [49]. L-form was mostly achieved artificially by growing them on osmoprotective media in the presence of high levels of antibiotics targeting the enzymes for cell wall synthesis [29,49]. Different from L-form, the non-walled spherical A. baumannii produced by β-lactam antibiotics survives in the media without any osmoprotective agent and was lack of an obvious bacterial proliferation under our experimental conditions. Consistently, it has been noticed previously that inhibition on the cell wall synthesis in several bacterial species does not always lead to cell lysis when they were grown in media without any osmoprotective agent [33,[50][51][52], suggesting that the non-walled spherical bacteria are a common morphological adaptation to β-lactam antibiotic killing. We classify these non-walled spherical A. baumannii generated by β-lactam antibiotics as persisters because they were a major faction in the bacterial survivors that typically represent the persisters defined based on the classic biphasic killing curve [5]. The survival of these cells was not due to the enhanced tolerance to antibiotics. Tolerance is a feature homogeneously beard by all the individual cells in the bacterial population, whereas persistence is a trait only found in a fraction of cells in such a population [31]. Even though most cells in A. baumannii could form nonwall spherical structure, a majority of them quickly burst and only a fraction of them survive. In addition, the non-walled spherical persisters are different from the dormant persisters, as they are metabolically active, and the antibiotics have taken full effect on their targets. In fact, we also observed dormant persisters with intact cellular structure in the fraction of A. baumannii persisters produced by meropenem killing, suggesting that the persisters of A. baumannii after β-lactam antibiotic killing are a population of mixture with heterogenous morphotypes resulting from distinct generating mechanisms.
Cell wall is instrumental for bacteria to prevent from bursting by high internal osmotic pressure. Previous studies showed that the outer membrane of stress-bearing bacteria contributes to the intact of non-walled bacterial cells [53,54]. It is unknown yet what makes the cell membrane of the non-wall spherical A. baumannii more elastic or stiffer to sustain high internal osmotic pressure so that cells can survive. Upregulation of fatty acid biosynthesis was known to be critical for the proliferation of L-form [55]. Consistently, inhibition on fatty acid synthesis by cerulenin apparently abolished the formation of spherical bacteria in A. baumannii (Fig. S6A), and the expression of A1S_0080 and A1S_0522, encoding putative β-Ketoacyl-ACP synthase I and II (FabB/F), respectively, was highly enhanced during meropenem treatment (Fig. S6B). Therefore, excess membrane synthesis, as observed for L-form, is likely one of the strategies for the non-wall spherical A. baumannii to survive, which needs further investigation. Since membrane is vital for bacteria from lysis after they lose the cell wall, interruption on the cell membrane would produce synergistic effect on the killing of bacterial pathogens. Colistin, a membrane targeting antibiotic being used for clinical chemotherapy, demonstrated a potent activity to enhance the bacterial killing of β-lactam antibiotics in vitro. The eradication of A. baumannii persisters by the combination of various antibiotics has been well studied recently [56]. While the combination of colistin and aminoglycoside amikacin demonstrated superior clearance on A. baumannii persisters, the combination of colistin with β-lactam imipenem also significantly reduced the persisters [56], which is consistent with our results. Thus, colistin might be a good candidate for combinational therapy with β-lactam antibiotics to treat A. baumannii infection. This result is also consistent with our previous studies that targeting bacterial persistence or tolerance could highly enhance the antibiotic treatment [27,57].
In summary, we have identified the non-walled, enlarged spherical A. baumannii as a major fraction of bacterial persisters. These persisters are featured by active metabolism and damaged cellular structure, and our results suggest that the combination of β-lactam with membrane targeting antibiotic(s) might be a good strategy for the treatment of A. baumannii infection.

Disclosure statement
No potential conflict of interest was reported by the author (s).